Latest Artificial pancreas Stories
Diabetes experts at a meeting convened by the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) took the next step in advancing efforts toward the development of an artificial pancreas: putting forth clinical recommendations to ensure the safe and effective testing of artificial pancreas technology in real-life situations.
DANBURY, Conn., Nov. 8, 2010 /PRNewswire/ -- Biodel Inc.
Renewal of U.S. Government Special Diabetes Program Will Ensure Progress toward Better Treatments and a Cure for Type 1 Diabetes NEW YORK, Nov.
Beta cells, which make insulin in the human body, do not replicate after the age of 30, indicating that clinicians may be closer to better treating diabetes.
DANBURY, Conn., Sept. 23 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) today reported recent findings from the company's diabetes drug research program during a poster session on short-acting insulins at the 46th annual meeting of the European Association for the Study of Diabetes in Stockholm.
DANBURY, Conn., July 12 /PRNewswire-FirstCall/ -- Biodel Inc.
Adding a continuous blood sugar level sensor to an insulin pump helps patients with type 1 diabetes achieve better blood sugar control compared to the common standard of care, multiple daily insulin injections.
In a step toward curing diabetes in humans, scientists at Washington University School of Medicine in St Louis have alleviated the disease in rats using transplants from both embryonic and adult pigs.
ORLANDO, Fla., June 26, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc.
SANTA BARBARA, Calif., June 25 /PRNewswire/ -- The University of California Santa Barbara (UCSB) and Sansum Diabetes Research Institute (Sansum) announced today the achievement of a milestone in the Artificial Pancreas Project funded by the Juvenile Diabetes Research Foundation (JDRF). The world's most flexible artificial pancreas system platform, currently being used in clinical trials around the globe, now has the benefit of compatibility with Animas Corporation insulin delivery products.
- A serpent whose bite was fabled to produce intense thirst.
More Images (1 images) »